![](images/sepfull.gif) |
Corporate News
29-Dec-21
|
![](images/sepfull.gif) |
|
|
|
|
|
J B Chemicals & Pharmaceuticals to launch Molnupiravir 200 mg in India
|
Used for treatment of mild Covid-19
|
|
|
J B Chemicals & Pharmaceuticals is set to launch Molnupiravir 200 mg for the Indian market. Marketed under the brand name Molunamax, it will soon be available all across the country in the next month for the treatment of mild COVID-19.
Recently Molnupiravir, received U.S. FDA, Emergency Use Authorization(EUA) for the Treatment of Mild to Moderate COVID-19. Molnupiravir should be administered as soon as possible after a diagnosis of COVID-19 has been made, and within five days of symptom onset. In India, the
CDSCO has recently recommended for grant of permission to manufacture and market Molnupiravir 200 mg capsule for restricted use under emergency situation in the country for treatment of patients above the age of 18 years, diagnosed COVID-19 positive, with SpO2 > 93%
and those who have a high risk of progression of the disease. The recommended dose for Molnupiravir is 800 mg (four 200 mg capsules) taken orally every 12 hours for five days, with or without food. Completion of the full five-day treatment course is important to maximize viral clearance and may help in minimizing the transmission of SARS-CoV-2.
|
|
Previous News |
J B Chemicals & Pharmaceuticals fixes record date for interim dividend
(
Market Beat
-
Reports
06-Feb-24
16:48
)
|
|
J B Chemicals & Pharmaceuticals consolidated net profit rises 26.48% in the December 2022 quarter
(
Results
-
Announcements
09-Feb-23
07:36
)
|
|
J B Chemical receives USFDA approval for Venlafaxine Extended Release Tablets
(
Corporate News
-
30-Nov-22
16:24
)
|
|
J B Chemicals & Pharmaceuticals consolidated net profit rises 92.58% in the June 2020 quarter
(
Results
-
Announcements
15-Sep-20
08:45
)
|
|
J B Chemicals & Pharmaceuticals allots 27,890 equity shares under ESOS
(
Corporate News
-
23-May-23
18:50
)
|
|
J B Chemicals & Pharmaceuticals consolidated net profit declines 21.15% in the September 2020 quarter
(
Results
-
Announcements
11-Nov-20
08:24
)
|
|
J B Chemicals & Pharmaceuticals Ltd leads gainers in 'A' group
(
Hot Pursuit
-
17-Sep-20
12:00
)
|
|
J B Chemicals & Pharamaceuticals standalone net profit rises 20.11% in the March 2015 quarter
(
Results
-
Announcements
20-May-15
17:59
)
|
|
J B Chemicals & Pharmaceuticals allots 5,320 equity shares under ESOS
(
Corporate News
-
13-Sep-22
17:37
)
|
|
J B Chemicals & Pharmaceuticals Ltd Surges 4.41%
(
Hot Pursuit
-
17-Sep-20
09:30
)
|
|
JB Pharma gets US FDA nod for depression treatment drug
(
Hot Pursuit
-
30-Nov-22
15:12
)
|
|
|
![](images/sepfull.gif) |
Other Stories |
![](images/sepfull.gif) |
|
|
|
|
|
|
|